Clinical efficacy of Tejashiladi vati in Diabetes Mellitus

Phase 1

Conditions: Health Condition 1: null- Patients with Madhumeha

Registration Number: CTRI/2016/04/006835

Lead Sponsor: Institute for Post Graduate Teaching and Research in Ayurveda Jamnagar

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot Yet Recruiting

Sex: Not specified

Target Recruitment: 60

Inclusion Criteria

1.Patients having Blood sugar â?? Fasting Plasma Glucose >= 126 mg/dl or

â?? Post Prandial Plasma Glucose >= 200 mg/dl or

or HB1AC level >7 and <10

2.Patients having classical symptomatology of Madhumeha (Prabhutamutrata, Avilamutrata, Galatalu Shosha, Asyamadhurya etc.) will be selected from OPD and IPD of IPGT & RA, Hospital, Jamnagar.

3.Patients fulfilling criteria 1 with or without criteria 2

4.Symptoms of Diabetes (Polyuria, Polydypsia, Polyphagia and Weight loss.)

Exclusion Criteria

1.Age below 30 and above 60 years.

2.Malignant and accelerated Hypertension.

3.Patients having chronic complications of Diabetes Mellitus

a.Microvascular: Retinopathy, Neuropathy, & Nephropathy.

b.Macrovascular: Coronary artery disease, Peripheral vascular disease & Cerebro-vascular disease.

c.Other chronic debilitating diseases like STD etc.

4.Pregnant women.

5.Lactating mothers.

6.Secondary Diabetes mellitus.

7.Patients of any other severe illness.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
t is expected that the trial drugs will exert a <br/ ><br>significant action on Signs and Symptoms of <br/ ><br>Madhumeha(Prabhutamutrata,avilmutrarata). Improvement in blood sugar level and other <br/ ><br>haematological parameters) <br/ ><br>(TLC, DLC, Hb,).Timepoint: upto 8 weeks with the follow up of 2 weeks

Secondary Outcome Measures